Dear Angel Investor,
Almost all of us have someone in our network that has been touched by cancer, whether a sister, a husband, a friend or a co-worker, perhaps even you. The devastation is massive - untold suffering by cancer patients and their families and astronomical medical bills. But there’s hope. Every day the press is reporting on new cancer treatments that lessen the suffering of radiation and chemotherapy. However, the oncology community agrees that early diagnosis is the best treatment - the sooner we can detect malignancy, or even predict it, the more likely we can keep cancer patients alive, and minimize their suffering.
Florida Analytics Imaging Solutions is proud to announce a unique opportunity to brighten the future in the fight against cancer. The FAIS team has developed and patented an astonishing breakthrough in cancer diagnosis: a novel liquid biopsy tool that allows oncologists to diagnose epithelial carcinomas - 90% of all cancer fatalities - in it’s earliest stages. But we need your help to bring this invention to the public. With your trust and assistance, together we can save millions of lives.
Unlike conventional, and invasive, surgical biopsies, our system allows healthcare professionals to diagnose cancer through Circulating Tumor Cells in the bloodstream. Our proposed device, powered by a deep learning neural network, isolates the part of the cell that controls cell growth - the centrosome - and through a unique algorithm analyzes the shape, size, number, and structure of Circulating Tumor Cell centrosomes to make a diagnosis. Our pilot experiments show a 85% accuracy rate for this system, and because it relies on a deep learning neural network that figure will only grow as more data becomes available. Additionally, because of prior work, we’re able to easily integrate these results with existing healthcare records and even make determinations about prognosis, the effectiveness of a treatment.
As you’ve seen here on our site, our leadership team has almost a century of combined experience in biomedical research, innovation and administration, holding nearly a dozen patents, research, faculty and administrative positions in the nation’s top institutions, and having been published in many top academic journals. But the FAIS team is no stranger to the havoc that terminal cancer can wreak. CEO Dr. Tatyana Zhukov lost her husband, Ukrainian American artist Boris Zhukov to pancreatic cancer in 2007. His life, and the lives of countless others, could have been saved if this technology had been available then.
But we have, in front of us, a chance to heal the past, and rewrite this tragedy for future generations. By supporting FAIS in its further development of this life saving innovation, you can make a difference today. Our quest is to make early cancer diagnosis as cheap and simple as a pregnancy test, and with your financial support we can.
* Secure Donations by PayPal
To get more information on FAIS solutions, method and technology, please download FAIS presentation here
or contact us today at
Help Us to Make a Difference!
Make A Donation
* Secure Donations by PayPal